コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 LMW cyclin E has prognostic and predictive roles in HER2
2 LMW fraction was further purified (LWM-FP) to remove sug
3 LMW HA was a potent stimulant of AA release in a time- a
4 LMW peptides (<1kDa) were obtained by the ultrafiltratio
5 LMW thiols also preserve the transcription of Salmonella
6 LMW-E induces additional mitotic defects in cooperation
7 LMW-E upregulated ACLY enzymatic activity, subsequently
8 LMW-GS from variety C 306 brought a decrease in the doug
10 blocked by the rfbA rffH mutations, lacks a LMW-dT pool, the initial DNA synthesis during T-starvati
11 ormation of surrounding proteins, and when a LMW ligand binds to the proteins, it can enhance protein
12 ubcellular localization may lead to aberrant LMW-E protein interactions, regulation, and activity, ul
17 implication of our findings is that altered LMW-E and LMW-E/Cdk2 subcellular localization may lead t
19 bulin 3A and 3C, chitinase, beta-amylase and LMW glutenins, were identified from the electrophoretic
21 on of our findings is that altered LMW-E and LMW-E/Cdk2 subcellular localization may lead to aberrant
23 , we show that full-length cyclin E (EL) and LMW-E overexpression impairs the G(2)-M transition diffe
25 ugh by the inclusion of gluten, glutenin and LMW-GS, which lacks resemblance among different samples,
31 de detailed insights into how collagen I and LMW-heparin impact different stages in the aggregation o
32 ho were exposed to HMW (n = 10, Group I) and LMW (n = 10, Group II) at their workplaces were collecte
33 VSMC in a NADPH oxidase-dependent manner and LMW-HA stimulated ROS generation and cell proliferation
34 entially metal-sensitive HMW (Ag and Ni) and LMW (Tl) pools, whereas the MMW pool, which includes met
37 +) of D. radiodurans exists predominantly as LMW complexes with nitrogenous metabolites and orthophos
38 assay for screening the interactions between LMW ligands and transcription factors (TFs) and human se
39 dings establish a novel relationship between LMW-E isoforms of cyclin E and aberrant lipid metabolism
40 A2, PATJ, or Dbs (RhoGEF) expression blocked LMW-HA-mediated angiogenesis (EC proliferation, migratio
42 We found that in predenitrification BNR, LMW-DON is released during the post-aerobic step followi
43 city to mount procatabolic responses to both LMW-HA and HMGB-1, demonstrated by >95% suppression of N
47 ollectively, the mitotic defects mediated by LMW-E induction led to failed cytokinesis and polyploidy
48 cessary for NADP(+) binding in the canonical LMW TrxRs, but also contains a 11-residue sequence which
49 less, irradiation of E. coli majorly changes LMW Mn(2+) speciation, with extensive binding of nitroge
50 atform is useful not only for characterizing LMW DOM, but also for quantifying relative variations in
54 ized that aberrant localization of cytosolic LMW-E isoforms alters target binding and activation ulti
57 s, resulting in the accumulation of distinct LMW peptides that promote protein aggregation in lenses
59 f low molecular weight isoforms of cyclin E (LMW-E) overexpression on mitotic progression and its lin
60 age products, low-molecular weight cyclin E (LMW-E), is associated with poor clinical outcome in pati
61 es show that HER2-mediated signaling effects LMW cyclin E expression, which in turn deregulates the c
62 traportal and systemic treatment with either LMW-DS or heparin, targeting an activated partial thromb
66 We also report that breast tumors expressing LMW-E have a higher proportion of CD44(hi)/CD24(lo) tumo
68 ssembly into fibrils, and both extracellular LMW Tau aggregates and short fibrils, but not monomers,
70 Bone marrow derived-macrophages from Fgf2(LMW-/-) mice co-injected with cancer cells reduce tumour
71 -based protein complementation assay to find LMW-E binding proteins in breast cancer, identifying ATP
76 for HMW fraction, +/- 0.54 per thousand for LMW fraction, and +/-1.3 per thousand for R fraction.
80 ctivity, correlated with shift of PDE3A from LMW to HMW peaks, and increased co-immunoprecipitation o
83 HMGB-1 and hyaluronidase 2 (which generates LMW-HA) to induce chondrocyte hypertrophy, which is impl
84 fic antibodies for gliadins, gamma-gliadins, LMW subunits and antigenic epitopes to gain a better und
85 and accumulation of low molecular weight HA (LMW-HA) in tumor tissue was associated with elevated pro
86 se, which generates low molecular weight HA (LMW-HA), is induced in VSMC in a NADPH oxidase-dependent
88 yaluronidase (Hyal) and low m.w. hyaluronan (LMW HA) fragments have been widely reported to stimulate
90 R-4 ligands low molecular weight hyaluronan (LMW-HA) and high mobility group box chromosomal protein
91 trated that low molecular weight hyaluronan (LMW-HA, approximately 2500 Da) promotes endothelial cell
92 findings establish a requirement for Cdk2 in LMW-cyclin E-mediated mammary tumorigenesis, arguing tha
93 pecifically test the requirement for Cdk2 in LMW-cyclin E-mediated mammary tumorigenesis, we generate
94 nd that Cdk2 silencing induced cell death in LMW-overexpressing breast cancer cell lines, but not in
97 , each log unit (roughly 3-fold) increase in LMW metabolites was associated with 21% and 22% increase
100 phloroglucinol polymerisation are present in LMW fractions of the three brown macroalgal species.
102 evel explanation for the function of TLR4 in LMW HA (200 kDa)-induced lung inflammation, as inhibitio
103 also for quantifying relative variations in LMW DOM availability across space, revealing hotspots of
104 tive and relative-quantitative variations in LMW DOM with depth using water extracts from a soil core
106 Lastly, downregulation of Cdc25C inhibits LMW-E-mediated chromosome missegregation, anaphase bridg
107 associated with modestly increased internal LMW phthalate and paraben exposure in 4-9 year old child
108 ession of the low molecular weight isoforms (LMW-E) of cyclin E induces chromosome instability; howev
113 inguish between and metabolize the two major LMW-SNO signaling molecules GSNO and SNO-CoA, allowing f
114 act mainly through IgE-mediated mechanisms, LMW agents appear to act through both immunological and
115 y and the multiligand receptors that mediate LMW protein uptake in PT cells, how these are regulated
118 ese findings indicate that AKR1A1 is a multi-LMW-SNO reductase that can distinguish between and metab
119 d to aggregate and subsequently form low MW (LMW) oligomers, high MW (HMW) aggregates such as protofi
120 of low-molecular-weight dissolved organic N (LMW-DON), which is highly bioavailable and stimulates ph
123 On the other hand, HMW oligomers, but not LMW oligomers, induced oxidative stress in hippocampal n
127 l specimens of breast cancer, the absence of LMW-E and low expression of adipophilin (PLIN2), a marke
128 cells as key players in the accumulation of LMW-HA in the tumor microenvironment and cancer-related
131 We report the discovery of a novel class of LMW-PTP inhibitors derived from sulfophenyl acetic amide
133 r future studies with more optimal dosing of LMW-DS for the prevention of IBMIR in islet transplantat
134 of this study was to determine the effect of LMW HA on cPLA2alpha activation, arachidonic acid (AA) r
135 ggest that targeting downstream effectors of LMW-HA could be a useful therapeutic intervention for an
136 ites, respectively, inhibited the effects of LMW-FGF-2 and HMW-FGF-23 to stimulate FGF-23 promoter ac
138 lability of mercury through the exudation of LMW thiols, and thus they may play a key role in the pro
139 ggesting that neither PH20 nor generation of LMW HA fragments in situ stimulates cytokine and chemoki
140 and demonstrate the potential importance of LMW DOC in driving the rapid metabolism of Pleistocene-a
142 44 or EphA2 siRNA and observed inhibition of LMW-HA-induced angiogenesis in implanted Matrigel plugs.
144 ite of phosphate, a competitive inhibitor of LMW-PTPs, on MptpA and elucidated the involvement of bot
145 single intracerebroventricular injection of LMW AbetaOs (10 pmol) induced rapid and persistent cogni
148 hese results suggest that the high levels of LMW-E isoforms found in breast cancer may contribute to
149 suggest that the heightened oncogenecity of LMW-E relates to its ability to promote CSC properties,
151 uch as that of SodA, with a minority pool of LMW Mn(2+) complexes that show negligible coordination b
152 time of fibril formation in the presence of LMW-heparin and slowing the rate at higher concentration
153 in sediments enables the rapid processing of LMW DOC, particularly during high C enrichment events an
154 ystem with the pleiotropic responsibility of LMW PAH-centric hydroxylation, and its epistatic functio
156 there is otherwise no sequence similarity of LMW-PTPs to other classes of PTPs, the phosphate binding
157 there have been no ligand-free structures of LMW-PTPs described, and hence the dynamics of the D-loop
159 nd MMW (42%) were more abundant than that of LMW (24%) in a diabetic patient with macroalbuminuria.
161 d significantly higher urinary levels of one LMW phthalate and two parabens, respectively, when compa
162 f cyclin E (low molecular weight cyclin E or LMW-E) in complex with CDK2 are preferentially mislocali
163 found that in strains lacking PBP5 and other LMW PBPs, higher FtsZ concentrations increased the frequ
166 uing that human breast tumors overexpressing LMW-cyclin E are prime candidates for anti-Cdk2 therapy.
167 lecular weight protein tyrosine phosphatase (LMW-PTP) is a regulator of a number of signaling pathway
169 n the redox-sensitive tyrosine phosphatases, LMW-PTP and SHP-2, which in turn results in increased ph
172 1, and PLK1 in a G(2)-M-enriched population, LMW-E overexpression causes premature inactivation of Cd
175 olecular weight penicillin-binding proteins (LMW PBP) have been difficult to discern in Gram-negative
176 olecular-weight penicillin-binding proteins (LMW PBPs) exhibit morphological alterations that also ap
177 ulosis, secretes a low molecular weight PTP (LMW-PTP), MptpA, which is required for its survival upon
179 low molecular weight thioredoxin reductases (LMW TrxRs), is an NADP(+)-independent dithiol oxidase.
180 due to the rffC defect, maintains a regular LMW-dT pool, but cannot recover dTTP from it, and thus s
181 s of microRNAs in low molecular weight RISC (LMW-RISC) not bound to mRNA, suggesting that these micro
191 , analyses of human tumor samples found that LMW-AR levels are higher in tumors that have an increase
198 cytokinesis and polyploidy, suggesting that LMW-E expression primes cells to accrue chromosomal inst
204 y of the Pdo system to oxidize biphenyl, the LMW PAHs naphthalene, phenanthrene, anthracene, and fluo
207 itial weak TPC, RSA and FRAP observed in the LMW fractions relative to the HMW fractions were substan
208 is that the overlap spans 16 residues in the LMW tropomyosin complex compared to 11 residues in the H
209 uces a striking conformational change in the LMW-PTP active site, leading to the formation of a previ
215 trand-specific targets demonstrates that the LMW replication intermediates come from both the lagging
221 tation (1.76 [1.07-2.91]), whereas OA due to LMW agents exhibited a higher risk of severe exacerbatio
224 ways inflammatory response after exposure to LMW and HMW agents by specific inhalation challenge test
226 g is essential for procatabolic responses to LMW-HA and HMGB-1, and MyD88 drives chondrocyte hypertro
227 mation on protein conformational change upon LMW ligand loading as can be observed from AuNPs' UV-vis
228 xplore our hypothesis, we compared EL versus LMW-E localization in cell lysates and in vivo using fra
229 eight of the agent (high molecular weight vs LMW) was the only factor associated with an increase in
230 ition [% decrease from the baseline (HMW vs. LMW) was 36.9 vs. 74.1% (Abeta40, P<0.05) and 25.4 vs. 8
231 generated fractions of low molecular weight (LMW) (<3.5 kDa) and of high molecular weight (HMW) (3.5-
232 as lysozyme and also a Low Molecular Weight (LMW) ACE effector, bilirubin, which act in concert to re
233 nal asthma (OA) due to low molecular weight (LMW) agents is not well established compared to classica
234 nant Tau misfolds into low molecular weight (LMW) aggregates prior to assembly into fibrils, and both
239 ence of (14)C-labelled low molecular weight (LMW) DOC at a wide range of concentrations (0.1 uM to 10
242 in the accumulation of low molecular weight (LMW) HA and activation of monocytes and macrophages.
243 itions in vivo, are of low molecular weight (LMW) independently of the organism, suggesting discontin
245 oughput screening of small molecular weight (LMW) ligands for protein and sensitive determination of
247 h comprises a range of low molecular weight (LMW) molecules (molecular mass < 150 Da) that differ fro
248 ect of addition of the low-molecular weight (LMW) organic compounds, easily ionized elements (EIEs),
251 reased accumulation of low molecular weight (LMW) peptides, similar to those found in aging human and
253 such that little to no low-molecular weight (LMW) products are externally released to the environment
254 his pathway results in low molecular weight (LMW) proteinuria that can progress to end-stage kidney d
256 elevated abundance of low molecular weight (LMW) thiols, including glutathione (GSH) and coenzyme A
259 rations of PAHs with lower molecular weight (LMW, 126 < MW < 202) and higher molecular weight (HMW, 2
263 ationally cleaved into low molecular weight (LMW-E) isoforms, which are tumor-specific and accumulate
266 parated into low- and high-molecular-weight (LMW and HMW) fractions by Sephadex LH-20 column chromato
267 to the accumulation of low-molecular-weight (LMW) "antioxidant" Mn(2+)-metabolite complexes that prot
268 cular-weight (HMW) and low-molecular-weight (LMW) Abeta oligomers in the brain ISF of living animals,
270 Here, we report that low-molecular-weight (LMW) and high-molecular-weight (HMW) Abeta oligomers dif
272 ght (HMW) proteins and low-molecular-weight (LMW) chemicals can cause occupational asthma (OA) althou
273 were fractionated, and low-molecular-weight (LMW) components were separated from the proteins by filt
274 s in either an active, low-molecular-weight (LMW) form or an inactive, high-molecular-weight (HMW) fo
275 istered anticoagulant, low-molecular-weight (LMW) heparin, in the initiation and subsequent aggregati
276 cancer and appears as low-molecular-weight (LMW) isoforms that correlate strongly with decreased sur
279 MS analyses of various low-molecular-weight (LMW) organic compounds, including alkaloids, saccharides
280 ior(s) responsible for low-molecular-weight (LMW) PAHs in HMW PAH-metabolic networks remain poorly un
281 including protein and low-molecular-weight (LMW) S-nitrosothiols (S-nitroso-GSH (GSNO) and S-nitroso
284 ytoplasmic pool of the low-molecular-weight (LMW) thiol glutathione (GSH) is readily oxidized in Salm
285 s does not produce the low-molecular-weight (LMW) thiol glutathione, but it does produce the LMW thio
286 s-127 reacted with the low-molecular-weight (LMW) thiol mycothiol, protecting it from overoxidation.
287 ercury complexation by low-molecular-weight (LMW) thiols can affect its bioavailability and thus the
288 stitutive secretion of low-molecular-weight (LMW) VWF is targeted basolaterally, toward the subendoth
289 olar concentrations of low-molecular-weight (LMW), high-molecular-weight (HMW), and di-2-ethylhexylph
290 ere we identify such a low-molecular-weight (LMW)-dT source as mostly dTDP-glucose and its derivative
294 s cell cycle arrest in prometaphase, whereas LMW-E overexpression reduces the length of mitosis and a
296 ata indicate that treatment of human EC with LMW-HA induced CD44v10 association with the receptor-tyr
297 solated from a human lens water-soluble (WS)-LMW fraction on a reversed-phase column and were identif
300 cellular enzymes (external hydrolysis) yield LMW products available to the wider bacterioplankton com